Evidence map›Paper›PMID 26337827›Full record

ArticleConnective tissue research2016

Synergistic enhancement of ectopic bone formation by supplementation of freshly isolated marrow cells with purified MSC in collagen-chitosan hydrogel microbeads.

Joel K Wise, Andrea I Alford, Steven A Goldstein, Jan P Stegemann

Abstract read
In one paragraph

Article in Connective tissue research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Hydrogel Microparticles for Bone Regeneration.Gels (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2017
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joel K Wisea Department of Biomedical Engineering , University of Michigan , Ann Arbor , MI , USA.
Andrea I Alfordb Department of Orthopaedic Surgery , University of Michigan , Ann Arbor , MI , USA.
Steven A Goldsteina Department of Biomedical Engineering , University of Michigan , Ann Arbor , MI , USA.
Jan P Stegemanna Department of Biomedical Engineering , University of Michigan , Ann Arbor , MI , USA.

Funding

Bone Regeneration Using Osteogenic and Vasculogenic Tissue ModulesR01AR062636 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STEGEMANN, JAN P. · 2014 to 2018
$1.7M
Modular Assembly of Interdigitated Osteochondral InterfacesR21AR062709 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STEGEMANN, JAN P. · 2013 to 2014
$343k
NIAMS NIH HHS R01 AR062636NIAMS NIH HHS R21 AR062709
6 · The paper itself

Abstract

purposeBone marrow-derived mesenchymal stem cells (MSC) can differentiate osteogenic lineages, but their tissue regeneration ability is inconsistent. The bone marrow mononuclear cell (BMMC) fraction of adult bone marrow contains a variety of progenitor cells that may potentiate tissue regeneration. This study examined the utility of BMMC, both alone and in combination with purified MSC, as a cell source for bone regeneration.

methodsFresh BMMC, culture-expanded MSC, and a combination of BMMC and MSC were encapsulated in collagen-chitosan hydrogel microbeads for pre-culture and minimally invasive delivery. Microbeads were cultured in growth medium for 3 days, and then in either growth or osteogenic medium for 17 days prior to subcutaneous injection in the rat dorsum.

resultsMSC remained viable in microbeads over 17 days in pre-culture, while some of the BMMC fraction were nonviable. After 5 weeks of implantation, microCT and histology showed that supplementation of BMMC with MSC produced a strong synergistic effect on the volume of ectopic bone formation, compared to either cell source alone. Microbeads containing only fresh BMMC or only cultured MSC maintained in osteogenic medium resulted in more bone formation than their counterparts cultured in growth medium. Histological staining showed evidence of residual microbead matrix in undifferentiated samples and indications of more advanced tissue remodeling in differentiated samples.

conclusionsThese data suggest that components of the BMMC fraction can act synergistically with predifferentiated MSC to potentiate ectopic bone formation. The microbead system may have utility in delivering desired cell populations in bone regeneration applications.

Indexed as

OsteogenesisAnimalsBone DensityBone Marrow CellsCell SeparationCell ShapeCells, ImmobilizedCell SurvivalChitosanChoristomaCollagenHydrogel, Polyethylene Glycol DimethacrylateImplants, ExperimentalMaleMesenchymal Stem CellsMicrospheresChitosanCollagenHydrogel, Polyethylene Glycol DimethacrylateBone formationbone marrow mononuclear cells (BMMC)chitosancollagenectopichydrogelmesenchymal stem cells

Identifiers

PMID26337827
PMCPMC4864208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.